Showing results (571-580 of 9,765) with videos related to
Sort By:
Pageof 977
Human Pathology|August 24, 2015
Intracrine steroid production and mammalian target of rapamycin pathways in pulmonary lymphangioleiomyomatosisKoko Adachi, Yasuhiro Miki, Ryoko Saito, et al.Human Pathology|August 25, 2015
Rare variants in the spectrum of human herpesvirus 8/Epstein-Barr virus-copositive lymphoproliferationsAlexandra Papoudou-Bai, Eleftheria Hatzimichael, Lydia Kyriazopoulou, et al.Human Pathology|December 29, 2014
Primary pulmonary hyalinizing clear cell carcinoma of bronchial submucosal gland originJoaquín J García, Long Jin, Shawn B Jackson, et al.Human Pathology|June 22, 2016
Clonal and genetic relationship between individual components of mucoepidermoid carcinoma: X-chromosome inactivation assay and microsatellite analysisWei Wang, Bingqing Zou, Hongguang Zhu, et al.Human Pathology|June 22, 2016
Pathologic features of aggressive vulvar carcinoma are associated with epithelial-mesenchymal transitionEmily R Holthoff, Horace Spencer, Thomas Kelly, et al.Human Pathology|May 6, 2019
Sinonasal undifferentiated carcinoma: clinicopathological spectrums and diagnosis reappraisalElmira Vaziri Fard, Songlin Zhang, Zhenjian Cai, et al.Human Pathology|May 6, 2019
Budding, tumor-infiltrating lymphocytes, gland formation: scoring leads to new prognostic groups in World Health Organization low-grade colorectal cancer with impact on survivalCorinna Lang-Schwarz, Balint Melcher, Franziska Haumaier, et al.Human Pathology|May 6, 2019
Addition of IMP3 to L1CAM for discrimination between low- and high-grade endometrial carcinomas: a European Network for Individualised Treatment of Endometrial Cancer collaboration studyNicole C M Visser, Louis J M van der Putten, Alex van Egerschot, et al.Human Pathology|August 1, 2018
Ectopic expression of band 3 anion transport protein in colorectal cancer revealed in an autoimmune hemolytic anemia patientShinichiro Kawamoto, Toyomi Kamesaki, Ryota Masutani, et al.Human Pathology|September 22, 2018
JAK2, PD-L1, and PD-L2 (9p24.1) amplification in metastatic mucosal and cutaneous melanomas with durable response to immunotherapySounak Gupta, Chad M Vanderbilt, Paolo Cotzia, et al.Pageof 977